Inventor · disambiguated record
Silke Baasner
Also filed as: BAASNER SILKE
11 granted patents·16 pending applications·141 citations·filing 1996–2025
88Inventor score
Files withFRESENIUS KABI DEUTSCHLAND GMBH7FRESENIUS KABI DE GMBH5ZENTARIS GMBH3SCHUSTER TILMANN2AE ZENTARIS GMBH1
Top patents by PatentIndex Score
27 records- 0193US8148546B2Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptorsSCHUSTER TILMANN·Filed 2008·Granted Apr 3, 2012·54 cites·14 claims
- 0288US6706722B2Heteroaryl derivatives and their use as medicamentsZENTARIS AG·Filed 2001·Granted Mar 16, 2004·55 cites·10 claims
- 0377US10272102B2Hydroxyalkyl starch for the treatment of hematological neoplasmsFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2014·Granted Apr 30, 2019·6 cites·16 claims
- 0475US7211588B2N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparationZENTARIS GMBH·Filed 2004·Granted May 1, 2007·7 cites·12 claims
- 0575US7205299B2Indole derivatives having an apoptosis-inducing effectZENTARIS GMBH·Filed 2004·Granted Apr 17, 2007·7 cites·21 claims
- 0667US8067456B2Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs)PAULINI KLAUS·Filed 2008·Granted Nov 29, 2011·2 cites·9 claims
- 0763US7375127B2Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs)AE ZENTARIS GMBH·Filed 2005·Granted May 20, 2008·1 cites·31 claims
- 0861US2013196949A1Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth ratesFRESENIUS KABI DE GMBH·Filed 2013·Application pending·0 cites
- 0960US2013197212A1Hydroxyalkyl starch for the treatment of head and neck cancers by reduction of tumor growth ratesFRESENIUS KABI DE GMBH·Filed 2013·Application pending·0 cites
- 1060US2013197211A1Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth ratesFRESENIUS KABI DE GMBH·Filed 2013·Application pending·0 cites
- 1158US2009311264A1Use of Disorazoles and Their Derivatives for the Treatment of Benign and Malignant OncosesAETERNA ZENTARIS GMBH·Filed 2009·Application pending·0 cites
- 1256US2016082036A1Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth ratesFRESENIUS KABI DE GMBH·Filed 2015·Application pending·0 cites
- 1355US5837462ATumorigenic cell lines altered by genetic engineering and their use for the testing of antitumor drugsASTA MEDICA AG·Filed 1996·Granted Nov 17, 1998·9 cites·7 claims
- 1451US2025248964A1Long-term efficacy of liver disease treatment with EPA and DHAFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2025·Application pending·0 cites
- 1549US2004106662A1Use of the disorazoles and their derivatives for the treatment of benign and malignant oncosesFiled 2003·Application pending·0 cites
- 1645US8541462B2Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptorsSCHUSTER TILMANN·Filed 2012·Granted Sep 24, 2013·0 cites·20 claims
- 1744US2005267303A1Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticalsZENTARIS GMBH·Filed 2005·Application pending·0 cites
- 1841US10202634B2Detection of starch levels in biological matricesFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2016·Granted Feb 12, 2019·0 cites·19 claims
- 1941US2020022941A1Long-term efficacy of liver disease treatment with EPA and DHAFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2018·Application pending·0 cites
- 2041US2004039197A1Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticalsFiled 2002·Application pending·0 cites
- 2141US2004110756A1New anthracene derivatives and their use as pharmaceutical preparationsFiled 2003·Application pending·0 cites
- 2241US2016175340A1Polysaccharide for use in preventing metastasis formation and/or relapseFRESENIUS KABI DE GMBH·Filed 2014·Application pending·0 cites
- 2339US2004097734A1Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncosesFiled 2003·Application pending·0 cites
- 2437US2019183961A1Glutamine for preserving, improving or restoring kidney functionFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2017·Application pending·0 cites
- 2537US2018021367A1Use of a mixture of modified glucose polymers for reducing tumor metastasisFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2016·Application pending·0 cites
- 2637US2002091124A12-acyl indole derivatives and their use as antitumor agentsFiled 2001·Application pending·0 cites
- 2733US11406614B2Composition comprising EPA and DHA for an enhanced efficacy of anticancer agentsFRESENIUS KABI DEUTSCHLAND GMBH·Filed 2017·Granted Aug 9, 2022·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Silke Baasner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →